PapersFlow Research Brief
Ophthalmology and Eye Disorders
Research Guide
What is Ophthalmology and Eye Disorders?
Ophthalmology and eye disorders in this context refer to the study of pathophysiology, management, and associated conditions of Graves' ophthalmopathy, including thyroid-associated ophthalmopathy, orbital fibroblasts, thyrotropin receptor antibodies, teprotumumab treatment, autoimmune mechanisms, surgical interventions for strabismus, and the involvement of the IGF-1 receptor.
This field encompasses 63,377 papers on Graves' ophthalmopathy and related eye conditions. Research addresses thyroid eye disease, autoimmunity, and treatments like teprotumumab. Growth rate over the past 5 years is not available in the data.
Topic Hierarchy
Research Sub-Topics
Graves' Ophthalmopathy Pathophysiology
This sub-topic covers autoimmune mechanisms, orbital inflammation, and extracellular matrix remodeling in thyroid eye disease. Researchers study cytokine profiles, adipogenesis in orbital fibroblasts, and immune cell infiltration.
Orbital Fibroblasts in Thyroid Eye Disease
This sub-topic examines the role of orbital fibroblasts in hyaluronan production, myofibroblast differentiation, and fibrotic changes. Researchers investigate TSH receptor and IGF-1R signaling pathways in disease progression.
Teprotumumab Treatment for Graves' Ophthalmopathy
This sub-topic focuses on clinical trials, efficacy endpoints, and safety profiles of IGF-1R antagonist teprotumumab. Researchers analyze proptosis reduction, diplopia improvement, and long-term remission rates.
Thyrotropin Receptor Antibodies in Ophthalmopathy
This sub-topic explores TRAb subtypes, pathogenicity, and correlations with disease activity in thyroid-associated ophthalmopathy. Researchers develop assays for antibody quantification and monitor treatment responses.
Surgical Interventions for Thyroid Eye Disease
This sub-topic covers orbital decompression, strabismus surgery, and eyelid procedures for rehabilitative management. Researchers evaluate techniques, complications, and functional outcomes in active versus inactive disease phases.
Why It Matters
Guidelines from "2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis" by Douglas S. Ross et al. (2016) provide 124 evidence-based recommendations for managing thyrotoxicosis, which contributes to Graves' ophthalmopathy, aiding clinicians in treating patients with thyroid-associated eye disorders. "Factors for Glaucoma Progression and the Effect of Treatment" by M. Cristina Leske (2003) showed that treated patients in the EMGT had half the progression risk compared to controls, with initial intraocular pressure reduction as a major factor, demonstrating treatment impacts on eye disease progression. "The Neurology of Eye Movements" by Richard Leigh and David S. Zee (2015) synthesizes anatomical and physiological substrates for eye movements based on macaque studies, informing management of strabismus and related surgical interventions in thyroid eye disease.
Reading Guide
Where to Start
"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis" by Douglas S. Ross et al. (2016), as it offers 124 evidence-based recommendations providing a foundational clinical overview of thyrotoxicosis management linked to Graves' ophthalmopathy.
Key Papers Explained
"Factors for Glaucoma Progression and the Effect of Treatment" by M. Cristina Leske (2003) establishes IOP reduction as a key factor halving progression risk in EMGT, building toward eye movement insights in "The Neurology of Eye Movements" by Richard Leigh and David S. Zee (2015), which details anatomical substrates from macaque studies relevant to strabismus; this connects to thyroid management in "2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis" by Douglas S. Ross et al. (2016), addressing thyrotoxicosis causes of ophthalmopathy; cerebellar roles from "The cerebellar cognitive affective syndrome" by Jeremy D. Schmahmann (1998) extend to higher-order eye control.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues on pathophysiology of Graves' ophthalmopathy, including orbital fibroblasts, thyrotropin receptor antibodies, and IGF-1 receptor, with focus on teprotumumab and autoimmune mechanisms; no recent preprints or news available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Functional evaluation : Barthel index | 1965 | Medical Entomology and... | 12.9K | ✕ |
| 2 | FUNCTIONAL EVALUATION: THE BARTHEL INDEX. | 1965 | PubMed | 5.9K | ✕ |
| 3 | The International Classification of Headache Disorders: 2nd ed... | 2003 | The Lancet Neurology | 5.1K | ✕ |
| 4 | The Neurology of Eye Movements | 2015 | Oxford University Pres... | 3.7K | ✕ |
| 5 | A theory of cerebellar cortex | 1969 | The Journal of Physiology | 3.3K | ✓ |
| 6 | The cerebellar cognitive affective syndrome | 1998 | Brain | 3.1K | ✓ |
| 7 | 2016 American Thyroid Association Guidelines for Diagnosis and... | 2016 | Thyroid | 2.7K | ✓ |
| 8 | The Global Burden of Headache: A Documentation of Headache Pre... | 2007 | Cephalalgia | 2.4K | ✕ |
| 9 | Migraine prevalence, disease burden, and the need for preventi... | 2007 | Neurology | 2.3K | ✓ |
| 10 | Factors for Glaucoma Progression and the Effect of Treatment | 2003 | Archives of Ophthalmology | 2.0K | ✕ |
Frequently Asked Questions
What is the role of IOP reduction in glaucoma progression?
In the EMGT, patients treated with IOP reduction had half the progression risk of control patients. Higher baseline IOP increased progression risk. "Factors for Glaucoma Progression and the Effect of Treatment" by M. Cristina Leske (2003) identified IOP reduction magnitude as a major outcome factor.
How do ATA guidelines address thyrotoxicosis management?
"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis" by Douglas S. Ross et al. (2016) developed 124 evidence-based recommendations. These guide care for thyrotoxicosis patients, including those with Graves' ophthalmopathy.
What substrates control eye movements?
"The Neurology of Eye Movements" by Richard Leigh and David S. Zee (2015) details anatomical, physiological, and pharmacological substrates for eye movements. It covers reflexive and voluntary gaze control from macaque electrophysiological studies.
What defines the Barthel index?
"FUNCTIONAL EVALUATION: THE BARTHEL INDEX." by Florence Mahoney and Dorothea W. Barthel (1965) provides a functional evaluation tool. It assesses patient independence in activities of daily living, relevant to eye disorder disability.
What is cerebellar cognitive affective syndrome?
"The cerebellar cognitive affective syndrome" by Jeremy D. Schmahmann (1998) describes cerebellum's role in higher-order functions. Neurological exams showed deficits in executive, linguistic, and affective processing.
Open Research Questions
- ? How do orbital fibroblasts and IGF-1 receptor interactions drive autoimmune responses in thyroid-associated ophthalmopathy?
- ? What are the long-term outcomes of teprotumumab treatment in Graves' ophthalmopathy patients?
- ? Which factors beyond IOP influence progression in glaucoma and strabismus surgery?
- ? How does thalamus infarction affect eye movement control in thyroid eye disease?
- ? What mechanisms link thyrotropin receptor antibodies to orbital inflammation?
Recent Trends
The field includes 63,377 works on Graves' ophthalmopathy, thyroid-associated ophthalmopathy, and related treatments, with no 5-year growth rate specified; no recent preprints or news coverage in the last 6-12 months indicates stable focus on established topics like teprotumumab and strabismus surgery.
Research Ophthalmology and Eye Disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ophthalmology and Eye Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers